14-3-3 蛋白通过抑制NF-κB通路来负面调节微质激活
William J Stone1, Frank Sanders Pair1, Roschongporn Ekkatine1
1Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Journal of neurochemistry
|September 11, 2025
概括
14-3-3蛋白调节中枢神经系统 (CNS) 中的微质炎症反应. 抑制这些蛋白质会加剧微质激活和细胞因子释放,这表明它们是治疗神经退行性疾病的关键标.
科学领域:
- 神经免疫学 神经免疫学
- 细胞生物学 细胞生物学
- 分子神经科学 分子神经科学
背景情况:
- 微质细胞是中枢神经系统 (CNS) 免疫细胞,涉及神经退行性疾病,如阿尔茨海默氏症,勒维体痴呆症和帕金森病.
- 14-3-3蛋白质是细胞功能的关键调节者,包括信号传递和细胞亡,并且在神经退行性疾病的大脑中显示水平降低.
- 14-3-3蛋白在微质炎症反应中的确切作用在很大程度上仍未被描述.
研究的目的:
- 研究14-3-3蛋白在微质炎症反应中的功能.
- 为了确定14-3-3抑制对微质激活和相关途径的影响.
- 探索14-3-3蛋白质作为中枢神经系统疾病的治疗点的潜力.
主要方法:
- 用脂聚糖 (LPS) 治疗不朽的BV-2和小鼠初级微质细胞.
- 使用14-3-3抑制剂 (BV02和二烯) 来阻止14-3-3蛋白与蛋白的相互作用.
- 评估了微质激活标记物,细胞化,细胞因子释放,化疗和NF-κB通路激活 (包括IKKβ和IκBα).
主要成果:
- 随着LPS治疗增加了微质中的14-3-3蛋白水平.
- 抑制14-3-3蛋白质显著增强了LPS诱导的微质激活,细胞化, lysosomal 蛋白质溶解和细胞因子释放.
- 14-3-3抑制降低了化学反应,并通过破坏14-3-3和IKKβ之间的相互作用来加速NF-κB通路激活,从而导致IκBα降解的增加.
结论:
- 14-3-3蛋白质在减轻微质细胞的炎症反应方面发挥着关键的调节作用.
- 干扰14-3-3功能增强了微质的炎症信号传递.
- 14-3-3蛋白代表了在中枢神经系统疾病中控制神经炎症的有希望的治疗点.
相关概念视频
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


